Allergy | Page 9 of 33 | SpiritIndia.com

Vitamin A :: A potential role for retinoic acid in autoimmune and inflammatory diseases

An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced today by researchers at the La Jolla Institute for Allergy & Immunology. The studies, conducted in laboratory mice, demonstrated the role of retinoic acid, a substance derived when vitamin A is broken down in the body, in regulating inflammation.

Peanut Allergy :: Tristar Food recalls Ferrari Chocolate due to undeclared peanuts and aflatoxins

Tristar Food Wholesale, 115 Amity Street, Jersey City, NJ 07304 is recalling Ferrari Chocolate because it contains undeclared peanuts.

Allergy :: WholeSoy issues Allergy Alert on undeclared dairy in Blueberry Yogurt

WholeSoy & Co. of San Francisco, CA is recalling 34,656 cups of WholeSoy & Co. Blueberry yogurt because it may contain undeclared dairy. People who have an allergy or severe sensitivity to dairy run the risk of serious or life-threatening allergic reaction if they consume these products.

Immunity :: Newly found sensing system enables certain bacteria to resist human immune defenses

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, have discovered a survival mechanism in a common type of bacteria that can cause illness. The mechanism lets the bacteria protect itself by warding off attacks from antimicrobial peptides (AMPs), which are defense molecules sent by the body to kill bacteria.

Smallpox :: US HHS buys next generation smallpox vaccine

US HHS Secretary Mike Leavitt announced that HHS has awarded a contract for $500 million to Bavarian Nordic A/S of Copenhagen, Denmark to manufacture and deliver 20 million doses of a next generation modified vaccinia Ankara (MVA) smallpox vaccine.

Tuberculosis :: NIAID releases MDR/XDR Tuberculosis research agenda

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), today released its NIAID Research Agenda for Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Tuberculosis (TB).

Snoring :: Snoring in children might be an allergic type disease

The research found that snoring is in fact part of the spectrum of childhood allergic diseases. So whilst the condition looks and sounds similar in adults and children it can have quite different causes and risk factors.

Allergy :: Investigating causes of childhood allergies and their long term impact

A University of Melbourne longitudinal family study investigating risk factors for childhood allergic disorders and their consequences, has received $850,000 from the National Health and Medical Research Council, announced by the Commonwealth Government last week.

Smallpox :: Innovative smallpox vaccine research study to be conducted at Case Medical Center

University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University School of Medicine are part of a nationwide research study to determine the safety and effectiveness of a new smallpox vaccine geared toward adults ages 18 to 34 who have never been vaccinated against the disease.

Sinusitis :: NIAID supports research into etiology of fungal-induced inflammation in chronic sinusitis

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI; Accentia) reports that the Mayo Medical and Graduate Schools and the Virginia Bioinformatics Institute have been awarded a National Institute of Health (NIH) grant of $2.4 million for a project entitled “The Pathogenesis of Chronic Rhinosinusitis.”